Blood Collection Tube for Liquid Biopsy Market Size Worth US$ 943.4 Million with 19.6% CAGR by 2035: Fact.MR Report

The world blood collection tube for liquid biopsy market was worth USD 157.5 million in 2025 and is expected to grow at a significant CAGR of 19.6% to reach USD 943.4 million by 2035.

The liquid biopsy blood collection tube market will grow considerably between 2025 and 2035. The cause of market expansion is the rise in cancer occurrence globally and immense interest in minimally invasive tests. Individuals require early disease diagnosis capabilities, and liquid biopsy technology is still under development.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Region-wise Insights

The North American market leads with the presence of robust healthcare infrastructure development along with high levels of liquid biopsy research funding and top company control, including industry leader Guardant Health, Thermo Fisher Scientific, and Bio-Rad Laboratories. The US market has a helpful regulatory system backing diagnostic tests undertaken via liquid biopsy techniques. The European market goes from strength to strength with its public cancer detection programs and compliance with IVDR, stimulating innovation in blood tube manufacturing.

Asia-Pacific is the most rapidly growing market segment for this sector because of the increasing incidence of cancer, emerging biotechnology industries in China, Japan, and South Korea, and government policies that promote precision medical uses. Expansion in the market is the result of greater awareness about how liquid biopsy can replace conventional diagnostic tests.

Category-wise Insights

CTC Tubes Dominate: CTC tubes dominate the market because of their pivotal role in the detection, monitoring, and targeted treatment of early cancer. Strong demand in North America and Europe is bolstered by robust oncology research and rigorous regulatory requirements.

Cancer Diagnosis & Monitoring Dominates by Application: The cancer diagnosis market is the largest, driven by increasing demand for non-invasive testing in high-incidence cancers such as lung and breast. Growth is driven by key players such as Guardant Health and Bio-Rad through research collaborations.

NIPT Continues to Grow Steadily: Non-invasive prenatal testing is growing, particularly in China and Japan, in spite of ethical and regulatory issues. Awareness and better healthcare policies drive growth.

Hospitals & Labs Continue to be Major End Users: Diagnostic labs and hospitals lead as more cancer and NIPT testing takes place. Higher automation and contamination control lead the way, with the U.S., Germany, and Japan taking the lead in liquid biopsy diagnostics.

Competitive Landscape

Key industry players in blood collection tube for liquid biopsy include Biocept Inc., F. Hoffmann-La Roche Ltd, Streck Inc., Norgen Biotek Corp, Exact Sciences Corp, MagBio Genomics Inc., Zymo Research Corporation, Apostle Sciences, QIAGEN NV, and Greiner Bio-One International GmbH among others.

Firms invest a substantial amount of their income in R&D to solve issues and provide innovative solutions to attract new customers and remain competitive. Firms are creating tailored solutions for issues that address industry-specific requirements in order to compete with other competitors.

A strong level of competition is witnessed in the market among well-established global players and novel biotech companies who engage in a struggle to formulate innovative stabilization techniques under regulatory regulations and suitable with NGS and PCR platforms. Market competition is dependent on technological improvements combined with regulatory needs and acquisitions through M&A activity and geographical business growth.

Market competition is significantly dependent on technological strategies that allow competitors to have varying product positions. Liquid biopsy blood collection tubes must address three significant challenges: biomarker protection, sample preservation, and effective DNA or RNA yield for analysis after analysis. Most businesses are leveraging advanced stabilization reagents, vacuum-sealed tubes, and contamination-resistant coatings to enhance their market positioning.

Technological advancements are the primary drivers of competitive market advancement.

A tailored solution averts damage to nucleic acids through guaranteed longer warehouse holding times for biomarker-sensitive tests without loss of test integrity.
Employing vacuum-sealed tubes provides accurate measurement collection, lowering both handling and transport errors.
Manufacturers strive to create collection tubes that effectively connect to NGS and PCR testing platforms.

Browse Full Report: https://www.factmr.com/report/4495/blood-collection-tubes-for-liquid-biopsy-market

Segmentation of Blood Collection Tube for Liquid Biopsy Industry Research

By Product Type:
ccfDNA Tubes
ccfDNA Isolation Kits
cfRNA Tubes
ccfRNA Isolation Kits
CTC Tubes
gDNA Tubes
gDNA Isolation Kits
Intracellular RNA Tubes
Intracellular RNA Kits
NIPT
By Material:
Glass
Plastic
By Application:
IVD
Research
End User:
R&D centres
Genetic Diagnostic Labs
Conventional Diagnostic Centres
Cancer Research Centers
By Region:
North America
Latin America
Western Europe
Eastern Europe
East Asia
South Asia & Pacific
Middle East & Africa

Check out More Related Studies Published by Fact.MR:

Cardiovascular Disease Monitoring and Diagnostic Devices Market
https://www.factmr.com/report/cardiovascular-disease-monitoring-and-diagnostic-devices-market

Suppositories Market
https://www.factmr.com/report/suppositories-market

Orthopedic Devices Market
https://www.factmr.com/report/4780/orthopaedic-devices-market

Bone Biopsy Systems Market
https://www.factmr.com/report/3884/bone-biopsy-systems-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.